DCOHF yields 4.87% · PFE yields 6.13%● Live data
📍 DCOHF pulled ahead of the other in Year 1
Combined, DCOHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DCOHF + PFE for your $10,000?
Dickson Concepts (International) Limited, an investment holding company, sells luxury goods. It operates in two segments, Sale of Luxury Goods and Securities Investment. The company sells fashion and accessories, watches and jewelry, cosmetics and beauty products, lighters, writing instruments, leather goods, and luxury goods. It also provides interior design, management consultancy and professional, services and operation of warehouses, trademarks agency, and import services. In addition, the company engages in the securities and property investment activities; arrangement of property tenancy agreements; and operation of Harvey Nichols, Beauty Avenue, and Beauty Bazaar stores. It operates 60 stores comprising 7 stores in Hong Kong, 30 stores in China, and 23 stores in Taiwan. The company was founded in 1980 and is headquartered in Tsim Sha Tsui, Hong Kong. Dickson Concepts (International) Limited is a subsidiary of Dickson Investment Holding (PTC) Corporation.
Full DCOHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.